Dan Milam

Executive Director, Global Head of Clinical Site Strategy

Aiolos Bio, a GSK Company, USA

With over twenty-five years of experience in the pharmaceutical, CRO, and site sectors, Dan has developed a broad perspective and deep understanding of the industry’s needs. At Aiolos Bio, he formulates and executes strategies to foster productive relationships with global clinical research partnerships, healthcare organizations, Key Opinion Leaders (KOLs), physicians, advisory boards, and organizations dedicated to clinical research initiatives. Dan actively engages with diverse industry partners and collaborates with internal teams to drive transformative change in clinical research, positioning Aiolos Bio as the preferred partner.

Speaker Sessions